Overview Fundamentals API Earnings EOD API Sample Code Pricing

Emmaus Life Sciences Inc (EMMA PINK) stock market data APIs

$0.071 0(0%) as of July 23, 2024
Price chart is built with Anychart

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its pipeline products include ELS001/ELS007, a pharmaceutical grade L-glutamine, which has completed phase 3 clinical trial to treat sickle cell disease; ELS004, a pharmaceutical grade L-glutamine which has completed phase 1 clinical study to treat diverticulosis; ELS005 in preclinical study for the use and combination of KM10544 to treat blood cancers; ELS003, a lab device/research tool in preclinical study to measure transmittance of cell sheet; and ELS002, a chondrocyte cell sheet technology to replace knee cartilage replacement or to treat osteoarthritis is in preclinical study. It has a license agreement with Kainos Medicine, Inc., which includes the patent rights of IRAK4 inhibitor (KM10544) for the treatment of cancers. The company was founded in 2000 and is headquartered in Torrance, California.

Emmaus Life Sciences Inc Financial Data Overview

4 410 K
61 846 K
29 597 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EMMA',
Type: 'Common Stock',
Name: 'Emmaus Life Sciences Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BQBTW8',
CIK: '822370',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic Primary',
IsDelisted: false,

Emmaus Life Sciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 29 597 K
  • EBITDA 3 572 K
  • Earnings Per Share -0.07
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Emmaus Life Sciences Inc Earnings via APIs

  • Latest Release 2024-04-30
  • EPS/Forecast 0.01

Get Emmaus Life Sciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?